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TITLE: Alcohol-related liver disease patients’ beliefs about their illness and factors that 
influence their self-management. 
 
ABSTRACT  
AIM  
To determine the association between illness belief and self-efficacy to provide the evidence-
base to develop a personalised framework to support self-management in patients with 
alcohol-related liver disease. 
 
BACKGROUND  
Research in a variety of long term illnesses suggests patients’ illness beliefs are a more 
influential factor for patient recovery than the severity of the illness. However, research into 
illness belief and self-efficacy of patients with alcohol-related liver disease is sparse.  
 
DESIGN 
A cross-sectional survey. 
 
METHODS 
A cohort of 159 alcohol-related liver disease patients who attended the Liver Outpatient 
Clinics at a London Hospital (October 2012 to November 2013) completed a set of validated 
instruments measuring illness beliefs, self-efficacy, emotional states and quality of life.  
 
FINDINGS 
The mean age of enrolled patients was 52 years, 67% male, 26% live on their own, 61% had 
no previous history of other chronic illness and average Model for End-Stage Liver Disease 
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and The AUDIT Alcohol Consumption Questions scores were 11.0 and 3.5 respectively.   
After adjusting for demographic and illness characteristic components, multiple regression 
analysis shows that the 3 illness belief components ‘Symptoms’, ‘Understanding’ and 
‘Concerns’ made a significant contribution to their confidence to self-manage their liver 
condition and the ‘Symptoms’ component makes a signification contribution across to all 
outcome measures: Anxiety, Depression, Quality of Life, and Self-Efficacy.   
 
CONCLUSION 
Interventions designed to improve alcohol-related liver disease patients understanding of their 
illness and strategies to manage their symptoms are likely to improve their self-management, 
quality of life and reduce anxiety and depression. 
 
KEY WORDS: alcohol-related liver disease, illness belief, self-efficacy, self-management, 
nursing. 
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SUMMARY STATEMENT  
Why is this research or review needed?  
• Alcohol-related liver disease has significantly contributed to the rise in hospital 
admissions and mortality rate, yet there is a lack of research about alcohol-related 
liver disease patients’ experience. 
 
• To provide an effective and evidence-based approach to promote self-management of 
alcohol-related liver disease it is important to have a clearer understanding of what 
influences these patients’ confidence to self-manage. 
 
• This study is the first study of alcohol-related liver disease patients to examine the 
relationship between illness belief and their confidence to self-manage their condition.  
What are the key findings?  
• The alcohol-related liver disease patients identify the most commonly experienced 
symptoms as ‘sleep difficulties’ and ‘fatigue’.  
 
• ‘Understanding of their liver condition’, ‘experience of the number of symptoms’ and 
‘concern about their illness’ are significantly associated with confidence to self-
manage in alcohol-related liver disease patients.   
 
 
• ‘Experience of the number of symptoms’ is significantly associated by alcohol-related 
liver disease patients with anxiety, depression, quality of life and the confidence to 
self-manage their chronic liver condition. 
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How should the findings be used to influence policy/practice/research/education? 
• Healthcare practitioners should address patients’ illness beliefs to create 
individualised responses to meet patients’ needs and better support self-management 
of their condition.  
 
• Strategies to address symptoms identified by alcohol-related liver disease patients are 
likely to improve their quality of life and confidence to self-manage, and reduce 
anxiety and depression.  
 
• Information obtained from patient illness beliefs and expectation assessment could be 
used systematically to formulate a personalised patient education plan to support 
health behaviour changes. 
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INTRODUCTION 
Liver disease is the 5th largest cause of death in the United Kingdom. The average age of 
death from liver disease is 59 years, compared to 82-84 years for heart & lung disease or 
stroke (British Association for the Study of the Liver (BASL) & British Society of 
Gastroenterology (BSG), 2009). Hospital admissions and the mortality rate in England are 
increasing for patients with chronic liver disease. The underlying reasons for this increase are 
complex, but alcohol-related liver disease (ALD) makes a major contribution to this rise in 
admissions and the mortality rate (Thomson et al., 2008). The rapid review of the evidence 
relating to liver disease epidemiology, treatment and service provision, identified the key 
modifiable risk factors that are relevant to a large proportion of patients with liver disease as: 
excessive drinking, infection with hepatitis B or C and obesity (Department of Health 2007). 
One of the key evidence gaps noted by the review was the need for research that includes 
patients’ perspectives and experience of treatment and care delivery (Kaner et al., 2007). The 
National Plan for Liver Service U.K. (BASL & BSG, 2009) has also reported the lack of 
research about chronic liver disease patients’ experience and the poor organisation of 
secondary care of liver disease.  
 
Evidence has shown that a motivational enhanced interviewing approach might help to 
modify health behaviour by challenging ALD patients’ illness perspective and experience 
(Weinrieb et al., 2011; Wilk et al., 1997). Physicians treating patients with ALD recommend 
a complex treatment plan involving health education to address modifiable risk factors and 
rigorous self-management practice to achieve optimal care. However, intervention to promote 
self-management in patients with a long term health condition is itself complex (Lau-Walker 
& Thompson 2009). To develop an effective evidence-based complex intervention (Medical 
Research Council, 2008) to promote ALD patients’ self-management it is vital to establish 
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what are the ‘active components’ that influence self-management. In order to support doctors 
and nurses to provide an effective and evidence-based approach to promote self-management 
for patients living in the community, it is important to have a clearer understanding of what 
influences patients’ confidence to self-manage their condition following discharge from 
hospital. 
 
BACKGROUND 
A personalised care approach is likely to optimise self-care management in patients with a 
long-term condition (Department of Health 2006) and evidence from a range of long term 
conditions including coronary disease (Ekman et al., 2012), asthma (Effing et al., 2009) and 
diabetes mellitus (Warsi et al , 2004) has suggested that a personalised care approach might 
improve healthcare outcomes.  The two psychological theories - illness representation 
(Leventhal et al., 1984; Leventhal et al., 2001) and self-efficacy (Bandura, 1997) - feature 
prominently in research in the development of a personalised care approach. An Interactive 
Care Model (Lau-Walker, 2006) was conceptualised combining the therapeutic use of these 
two psychological theories which aims to promote a personalised care approach by 
addressing patients’ illness perceptions (illness representation) and their confidence in self-
management (self-efficacy). Research findings based on the Interactive Care Model (Lau-
Walker, 2006) in patients with a long term cardiac condition suggest that the two key 
components of illness beliefs (identity and control/cure) are significantly associated with 
patient self-management and quality of life in the long term (Lau-walker, 2007; Lau-Walker 
et al., 2009). Research of ALD patients’ illness perception and self-management is sparse. To 
our knowledge, the current study which will apply the Interactive Care Model (Lau-Walker, 
2006) to patients with ALD is the first study to examine ALD patient’s illness beliefs, their 
confidence in self-management and quality of life. We hypothesise that ALD patients' 
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perception of their illness symptoms (identity) is associated with their self-management 
confidence, anxiety and depression and quality of life. 
 
THE STUDY 
 
Aims 
Aim of the study was to determine the association between illness perception and confidence 
in self-management; and to provide the evidence-base for the development of a personalised 
framework to support self-management in patients with alcohol-related liver disease.   
 
Primary question 
Are chronic liver disease patients’ perceptions of their illness symptoms associated with their 
confidence to self-manage and their quality of life? 
 
Study objectives  
1. To explore and describe ALD patients’ illness perception. 
2. To assess the association between ALD patients’ illness perception and their confidence to 
self-manage, anxiety and depression and quality of life.  
3. To explore the association between ALD patients’ characteristics (including self-reported 
alcohol intake - The AUDIT Alcohol Consumption Questions (Audit C) scores and severity 
of alcoholic-related liver disease - Model for End-Stage Liver Disease (MELD) scores) and 
their confidence in self-management, anxiety and depression and quality of life. 
 
Design 
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A cross sectional survey was carried out with ALD patients who attended the Liver 
Outpatient Clinic at a London Hospital (KCH) over a period of 12 months (October 2012 to 
November 2013) were invited to participate in the study and to complete a set of validated 
instruments measuring illness beliefs, self-efficacy, emotional states and quality of life.   
 
Participants  
 
Inclusion Criteria 
-Patients with a confirmed primary diagnosis of alcohol-related liver disease as determined 
by the hepatologist caring for the patients and who were attending the liver outpatient clinics 
at a London Hospital were eligible for the study.  
 
Exclusion criteria 
-Patients below 18 years of age 
-Patients unable to understand and read English unaided which would affect their ability to 
participate in the study 
-Patients with severe cognitive impairment which would affect their participation in the study 
 
Sample size 
To detect a relationship between the Self-efficacy measures and the Illness Perception 
Questionnaire components described by a regression line with slope of 0.45 based on 
previous studies (Lau-Walker, 2004; Lau-Walker, 2007), assuming an SD of the Self-efficacy 
of 1.0 and an SD of 0.5 for the Brief Illness Perception Questionnaire components (Broadbent 
et al., 2009), a sample size of 150 was sufficient to test the effect specified with 80% power 
and a 5% level of significance.   
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Data collection 
Patients who attended the ALD Liver Outpatient Clinic at a London Hospital (KCH) were 
screened by an ALD Nurse Specialist and the patients who met the inclusion criteria were 
invited to participate in the study. After gaining informed consent the participants completed 
a set of validated questionnaires to assess their illness perception, self-efficacy, quality of life 
and emotional state. Additionally an assessment of patient alcohol intake and severity of the 
liver condition was undertaken using the Audit-C tool and the MELD score respectively.  
 
Ethical considerations 
Ethical approval was obtained from the National Research Ethic Service Committee-Fulham 
(REC reference 11/LO/0472) and the study was registered with the Research and 
Development at a London Hospital (REC Ref: KCH11-085). 
 
Measures 
The instruments used in this study have proven validity and reliability. Wherever possible the 
short forms of these measures were selected to reduce barriers to participation in line with the 
research team’s previous experience of chronic liver disease patients’ behaviour with survey 
returns. As a result the following measures were chosen and used: 
 
Independent variable 
Illness beliefs: The Brief Illness Perception Questionnaire (BIPQ) (Broadbent et al., 2009) 
was developed to provide a quantitative assessment of the illness perception components 
described in Leventhal’s Self-regulatory Model (Leventhal et al., 2001). The BIPQ has been 
validated as a short form measure developed from the original Illness Perception 
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Questionnaire (IPQ) (Weinman et al., 1996) and the Illness Perception Questionnaire-Revised 
(IPQ-R) (Moss-Morris et al., 2002). Broadbent et al (2009) reports the psychometric 
properties of the BIPQ including the test-retest reliability, concurrent validity, predictive 
validity and discriminant validity of the BIPQ with IPQ, IPQ-R and other relevant measures 
and, in summary, the evidence shows the BIPQ to be a valid and reliable measure of the 
illness perception with a variety of illness groups. The 8 BIPQ components: ‘Consequence’ 
(illness effect on their life), ‘Timeline’ (length of illness), ‘Personal control’ (feel in control), 
‘Treatment control’ (treatment can help illness), ‘Identity’ (experience of symptoms), 
‘Concern’ (concern of illness), ‘Understanding’ (understanding of illness) and ‘Emotions’ 
(affected emotionally) were used to assess patient’s perception of their illness. Apart from the 
8 BIPQ components, the original IPQ identity dimension scale ‘Symptoms’ was also used in 
this study to provide a more detailed analysis of the patient’s identity beliefs (Broadbent et 
al., 2009). For each component a low score was good and a high score was bad e.g. 
consequence ‘How much does your illness affect your life’ 0 = ‘No affect at all’ and 10 = 
‘severely affects my life’. The ‘Symptoms’ –identity dimension scale reflect the individual’s 
perception what the problem was and requires participants to rate how often (never, 
occasionally, frequently and all the time) they experienced a list of ALD illness related 
symptoms (n=15) and they were added together to produce a summary score (Weinman et al., 
1996). A collinearity analysis of the eight BIPQ components and original IPQ did not indicate 
that this was a problem (the condition index was 22.1 below the threshold of 30 suggested for 
potential removal of variables from the model (Belsey & Kuh 1980, Belsey 1991). 
 
Outcomes measures 
1.  Confidence in self-management (SE): The Self-Efficacy for Managing Chronic Illness 
Scale consists of eleven statements rated on a 10 point scale to produce two summary scores 
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on Self-Efficacy Chronic (SE Chronic) and Self-Efficacy Liver (SE Liver). These scales were 
developed from Lorig et al’s (2001) work on several self-efficacy scales for Chronic Disease 
Self-Management studies.  
- The ‘SE Chronic’ scale consists of six statements to measure patient confidence in their 
ability to manage their illness in relation to fatigue, pain, emotional and symptom distress and 
performing daily tasks. Lorig et al (2001) reports the test for Internal Consistency and 
Reliability of the SE Chronic scale on 605 subjects (mean 5.17 SD ±2.22) with chronic 
illness was 0.91. 
-The ‘SE Liver’ scale consists of five statements to measure patients’ confidence in the 
management of the modifiable risk factors such as diet, exercise, smoking, alcohol intake and 
adherence to medicine. The scale was tested for internal consistency and Cronbach alpha 
reliability coefficient was 0.83.  
For both scales a statement score of 0 equated to feeling ‘not at all confident’ and a score of 
10 to feeling ‘totally confident’.   
 
2. Emotional state: The Hospital Anxiety and Depression Scale (HAD) (Zigmond & Snaith, 
1983) is a self-assessment scale and was found to be a reliable instrument to detect states of 
‘Depression ‘ and ‘Anxiety’ in the setting of an hospital medical outpatient clinic (Zigmond 
& Snaith, 1983). It has been widely used in healthcare settings to measure psychological 
well-being. It consists of 14 questions measured on a four-point scale from 1 = low to 4 = 
high. For example if a person said they were tense or wound up ‘most of the time’ they 
received a score of 1, and 4 if ‘not at all’. 
 
3. Quality of life: The EuroQoL Health Questionnaire (EQ-5D) (EuroQoL Group, 1990) was 
used. It is a standardised non-disease-specific instrument for describing and valuing health-
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related quality of life. The EuroQoL Group (1990) summarised the development and reported 
the instrument consistency testing (the multiple regression results showed that the value of R2 
in all three cases is very close to 1) in the three extensive studies conducted in the United 
Kingdom, Netherlands and Sweden. The ‘EQ-5D’ instrument has been validated for use in 
economic evaluation and was originally designed to be used in combination with other 
quality of life measures and more recently it has been used independently to produce 
summary scores for quality of life. Participants were asked to describe ‘Your own health state 
today’ on a 10-point scale from 0-10 ‘Worst imaginable’ to 91-100 ‘Best imaginable health’.  
 
 
Other measures used to assess patient characteristics 
Audit C score: is a brief screening test consist of 3 alcohol consumption questions extracted 
from the Alcohol Use Disorders Identification Test (AUDIT) tool and is used for the 
assessment of heavy drinking and/or mental and behavioural disorders due to use of alcohol. 
Bush et al (1998) evaluate the validity and reliability of the Audit C tool as a brief screening 
test for heavy drinking and/or active alcohol abuse or dependence and found that the AUDIT 
C is a practical and validated tool. The AUDIT C has been widely adopted into primary care 
settings and a score of 5 or above is considered to be hazardous drinking (Bradley et al., 
2007).  
 
MELD score: MELD score is calculated from serum creatinine, prothrombin time (INR) and 
serum bilirubin to produce a summary score that reflects the severity of patients’ liver 
condition (Dooley et al., 2011). MELD score is a scoring system to measure severity of 
chronic liver disease and subsequently it has been used successfully to predict mortality in 
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patients awaiting transplant and on average, patients with a MELD of 20 are considered for 
transplantation (Dooley et al., 2011).  
 
People were classified as having comorbidity if they listed one or more (e.g. severe kidney 
disease, cardiovascular disease, cancer, diabetes, high blood pressure etc.). 
 
For the regression analysis demographic and profile variables used in the model were 
dichotomised into whether the following characteristics were present or absent: male, has a 
partner, lived alone, racial background was white, employed, been awarded a degree, were a 
smoker and had one or more comorbidities. Obesity was categorised into three groups (BMI 
≥ 30, BMI <30, BMI unknown). 
 
Data analysis 
Multiple regression analysis was used to examine the association between illness belief 
components and the five outcome measures ‘Anxiety’, ‘Depression’, ‘EQ-5D, ‘SE Chronic’ 
and ‘SE Liver’. The primary aim of the study was to assess the association between patient 
illness beliefs and their confidence in the self-management of their chronic liver condition. In 
the multiple regression analysis, each of the independent variables was evaluated in terms of 
its independent predictive power, over and above all the other independent variables in the 
model. All regression (partial R2) results are reported as beta coefficients along with 95% 
confidence intervals. Normality probability plots and residual scatter plots were used to test 
the normality assumptions for the multiple regression models. All analyses were performed 
using IBM SPSS Version 22. 
 
RESULTS 
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Demographic and illness characteristics data 
Between October 2012 and November 2013, 159 ALD patients completed the questionnaire 
pack. Patients ages ranged from 27 to 80 (mean 52.3) and two thirds were male. Many were 
married or with a partner (54%); 19% were single. Eighty one percent were white and the 
level of qualifications ranged from none (18%) to university degree (25%). While 26% of 
patients reported that they were in employment or on sick leave, 26% were unemployed and 
19% were retired. On their BMI index 34% of patients were unsure about their score while of 
those who were sure 25% (BMI ≥30) were obese and 75% (BMI<30) were not; and 29% of 
patients reported they were current smokers. Patients’ mean MELD and AUDIT C scores 
were 11.0 (range 6-28) and 3.46 (range 0-12) respectively and 38% (n=61) of all patients did 
not have any other chronic condition/comorbidity (see Table 1). 
 
Table 1  
 
Illness Belief, emotional state, confidence in self-management and quality of life data  
The illness belief that produced the highest score was ‘Timeline’, followed by ‘Concerns’. 
The lowest scoring illness beliefs were ‘Treatment control’ followed by ‘Personal control’ 
and ‘Understanding’. Overall, patients recognised that their ALD was a long term condition 
and displayed concern about their illness. Patients appeared to suffer greater levels of 
‘Anxiety’ than ‘Depression’ based on HADs (Mean 2.76 vs. 3.14) and were more confident 
about management of modifiable lifestyle factors such as diet, physical exercise, smoking, 
adherence to medication and abstaining from or modifying alcohol intake (SE Liver 
Mean=7.42) than they were with managing the long term physical and emotional aspects of 
the disease and managing daily tasks (SE Chronic Mean=5.79) (Table 2). 
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Table 2  
 
ALD patients’ perception of their illness symptoms are described in Table 3 when patients 
were asked to score how often they experienced each of the listed symptoms. The result 
indicated that more that 50% of the patients in this survey experienced ‘sleep difficulties’ and 
‘fatigue’ frequently or all the time. The next of the most commonly experienced symptoms 
were ‘sore joints’ and ‘concern about illness complications’ and more than 40% of the 
patients experienced these symptoms frequently or all the time. The least commonly 
experienced symptoms were ‘jaundice’ and ‘pain in the right upper abdomen’. 
 
Table 3 
 
Association between Illness Beliefs and emotional states 
Regression analysis showed that Anxiety (Table 4a) and Depression (Table 4b) were 
associated with several factors. ‘Symptoms’ (β = -0.77 95% CI =-1.00 to -0.54, p<0.001, 
partial R2 = 0.31) and ‘Emotions’ (β = -0.07 95% CI =-0.11 to -0.03, p=0.002, partial R2 = 
0.10) were significantly associated with ‘Anxiety’ (Table 4a) and ‘Symptoms’ (β = -0.38 
95% CI =-0.56 to -0.19, p<0.001, partial R2 = 0.15), ‘Emotions’ (β = -0.04 95% CI =-0.07 to 
0.00, p=0.030, partial R2 = 0.05), ‘Personal control’(β = -0.04 95% CI =-0.07 to -0.01, 
p=0.009, partial R2 = 0.07), ‘Consequences’ (β = -0.04 95% CI =-0.07 to -0.01, p=0.022, 
partial R2 = 0.05) and ‘Current smoker’ (β = -0.23 95% CI =-0.40 to -0.07, p=0.007, partial 
R2 = 0.07) were significantly associated with ‘Depression’ (Table 4b). 
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Overall, patients’ who experience a high number and frequency of illness related symptoms 
and who perceive their illness has a high emotional impact on them are more anxious. 
Patients who experience a high number and frequency of illness related symptoms, perceive 
their illness to have a high emotional impact on them, feel less in control personally, and 
perceive their illness has a high consequence on their life and who are current smokers are 
more depressed. 
   
Table 4 
 
Association between Illness Beliefs and quality of life 
 ‘Symptoms’ (β = -0.92 95% CI =-1.80 to -0.03, p=0.043, partial R2 = 0.04) was the only 
independent variable significantly associated with EQ-5D (Table 5). Patients who experience 
a high number and frequency of illness related symptoms have a poorer quality of life.  
 
Table 5 
 
Association between Illness Beliefs and confidence in self-management 
‘Symptoms’ (β = -1.84 95% CI =-2.72 to -0.96, p<0.001, partial R2 = 0.15), ‘Personal 
control’ (β = -0.22 95% CI =-0.36 to -0.09, p=0.002, partial R2 = 0.10) and ‘Treatment 
control’ (β = -0.16 95% CI =-0.31 to -0.01, p=0.035, partial R2 = 0.04) were significantly 
associated with SE Chronic (Table 6a) and ‘Symptoms’ (β = -1.39 95% CI =-2.17 to -0.60, 
p=0.001, partial R2 = 0.11), ‘Concerns’ (β = 0.19 95% CI =0.06 to 0.32, p=0.006, partial R2 
= 0.08), ‘Understanding’ (β = -0.20 95% CI =-0.33 to -0.07, p=0.004, partial R2 = 0.08), 
Audit C (β = -0.15 95% CI =-0.24 to -0.07, p<0.001, partial R2 = 0.12), Male (β = -0.98 95% 
CI =-1.70 to -0.25, p=0.009, partial R2 = 0.07) and ‘Current smoker’ (β = -0.84 95% CI =-
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1.56 to -0.12, p=0.023, partial R2 = 0.05) were all significantly associated with SE Liver 
(Table 6b). 
Patients who experience a high number and frequency of illness related symptoms, who 
perceive their treatment is less likely to help their illness and who feel less in control 
personally are less confident in the management of their chronic condition.  
 
Patients who experience a high number and frequency of illness related symptoms, who have 
a poorer understanding of their liver condition, who are more concerned about their illness, 
who reported that they had a higher alcohol intake, are male and who are currently a smoker 
have less confidence in the management of their alcohol-related liver condition. 
 
Table 6 
 
In the  multiple regression models (Tables 4,5 & 6), a number of the demographic and illness 
characteristic variables were found to be significantly associated with the outcome measures,  
smoking was significantly associated with ‘Depression’; alcohol intake, smoking and gender 
were significantly associated with ‘SE Liver’; while having other chronic illnesses was 
significantly associated with ‘EQ-5D’. Finally, it is also interesting to note that the MELD 
score which represents the severity of the liver condition made no significant contribution to 
any of the outcome measures such as self-efficacy, anxiety and depression and quality of life. 
 
DISCUSSION 
The design of the current study aimed to assess patients’ ‘illness beliefs’ and their ‘self-
efficacy’ to provide evidence for the development of effective personalised patient 
education/care. Assessment of patient’s illness beliefs can be used to understand their 
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personal illness perspectives, while the assessment of patients confidence to manage their 
condition - Bandura’s self-efficacy, which he identifies as ‘a powerful determinant of 
behavioural change’(Bandura 1997) - can be used to inform strategies to promote self-
management.  By understanding the associations between patients’ individual illness belief 
components and self-efficacy, healthcare professionals gain valuable information to better 
help their patients make sense of their illness beliefs and to make connections between these 
beliefs and any available relevant educational material, and, consequently, to improve the 
exploration of the individual’s self-management strategies for the relevant modifiable health 
behaviour changes.   
 
Research evidence has shown that to provide generic health education information does not 
necessarily help patients to adopt the suggested health behaviour changes. To be effective 
patient education needs to be personalised (Mullen et al., 1992). For example, only educating 
patients about harmful effects of smoking, lack of exercise, and diet on their health condition 
often does not enable patients to make or sustain their health behaviour changes. Patients are, 
however, more likely to act on the educational material that they can understand and find 
relevant and meaningful to their individual needs or circumstance (Bandura, 1997).   
 
To develop an effective personalised patient education intervention to support self-
management the information provided to patients needs to be specific and situation related 
(Lau-Walker & Thompson, 2009). This study sought to examine ALD patients’ illness 
experience and to establish the evidence for the development of personalised patient 
education to support self-management in ALD patients. Hence, the current study sought to 
assess in detail patients’ views and experience of their associated illness symptoms using the 
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IPQ identity dimension ‘Symptom’, to understand how often patients experience their illness 
symptoms (Table 3). 
 
As shown in Table 3, individual beliefs and experiences are more likely to shape the 
effectiveness of the patient’s care than the severity of the patient’s condition. Research has 
shown that patients’ illness beliefs and expectations are more influential than the severity of 
patients’ illness condition to their health behaviour changes (Petrie & Weinman, 1997).  
Indeed, the study findings indicate that the MELD score, which represents the severity of the 
liver condition, made no significant contribution to any of the outcome measures of self-
management, anxiety and depression, or quality of life. 
 
Confidence to self-manage  
The study’s data show that patients’ experience of number and frequency of their illness 
symptoms (‘Symptoms’), their sense of personal control (‘Personal control’) and believe that 
treatment can help (‘Treatment control’) are the key factors that influence their confidence in 
their ability to manage their chronic condition. ‘Symptoms’ is also significantly associated 
with anxiety, depression and quality of life. These results are consistent with other research 
findings in the self-management of other chronic illness conditions such as chronic heart 
failure, chronic obstructive pulmonary disease and diabetes (Ekman et al., 2012; Effing et al., 
2009; Warsi et al., 2004). The IPQ ‘Symptoms’ identity dimension scale has consistently 
emerged in studies of chronic illness self-management as an important variable that is 
significantly associated with health outcomes or health behaviour changes (Petrie & 
Weinman, 1997).   
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The current study has shown that when patients respond to self-efficacy questions specifically 
related to the self-management of their liver condition (SE Liver), as well as ‘Symptoms’, 
two other illness belief components ‘Understanding’ and ‘Concerns’ were identified to be 
significantly associated with patients’ confidence in self-management (SE Liver). Therefore, 
to promote self-management in ALD patients, it is also important to ensure patients 
understand their liver disease, that measures are taken to help patients to address the illness 
concerns they themselves identify, and that they are able to recognise and manage their 
illness symptoms effectively. One noteworthy result shows a different direction of association 
that patients who are more concerned about their illness have more confidence in the ability 
to manage their alcohol-related liver condition which is not expected; the findings suggests 
that it is important to raise patient awareness and concern of the consequence of their alcohol-
related liver condition to encourage patients to develop their confidence in managing their 
alcohol-related condition.   
 
Personalised patient education and care 
A review of Liver Services in the UK has identified the urgent need to ensure that healthcare 
practitioners who care for patients with liver illness should have adequate and specific 
knowledge and skills (DH, 2011; BASL & BSG, 2009) and a set of national liver care 
competences has been developed as guidelines to ensure good practice (RCN, 2013). In 
addition, to provide an effective liver service there is a need to develop effective personalised 
patient education based on the illness beliefs of the patients being supported. The IPQ 
‘Symptom’, ‘Personal control’, ‘Treatment control’, ‘Concerns’ and ‘Understanding’ are the 
five IPQ components that have been found to be related to patients’ confidence to self-
manage. These findings provide us with an insight into patients’ personal perspectives of 
their illness and, together with the associations between patients’ illness perspectives and 
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their confidence in their own self-care provides useful information to develop individual 
strategies to promote ALD patient self-management. The management of realistic 
expectations and a clear understanding of the illness condition informed by relevant and 
individualised information are vital for the successful support of self-management.  
 
Development of personalised self-management strategies 
Previous research has suggested that there is a marked divergence of focus between patients 
and doctors on what is important to identify priorities to address their condition (Wenger et 
al., 1984; Calkins et al., 1991; Lau-Walker et al., 2009).  Doctors tend to focus on the 
symptoms generated by the severity of the condition or its prognosis, and undervalue the 
symptoms patients report. Rather than the severity of their condition, patients placed more 
focus on the limitations their illness imposes on their daily activities which impact on their 
quality of life.  
 
In the current study we examined patient views of their illness associated symptoms using the 
IPQ identity dimension scale and found that the two most common symptoms experienced by 
ALD patient are ‘fatigue’ and ‘sleeping difficulties’. Observations have shown that 
physicians treating ALD patients are more likely to prioritise the assessment and treatment on 
patients’ physical symptoms such as ‘jaundice’ and ‘upper abdomen pain’- which, of the 
symptoms listed in this study, are the two which patients give least priority (Table 3-
‘Symptoms’). Physicians are less concerned with the treatment or advice to patients on the 
management of ‘fatigue’ or ‘sleeping difficulties’, which patients place at the top of their list 
of symptoms they are concerned about (Table3- ‘Symptoms’).  
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This lack of a shared focus between patients and their health carers is likely to lead to a sub-
optimal improvement of the patients’ quality of life and self-management of their illness. The 
study findings would suggest that in providing patient-centred care, it is important that we 
address patients’ key concerns and prioritise the treatment and care of symptoms such as 
‘fatigue’ and ’sleeping difficulties’ in these patients.  
 
Implications for practice 
To establish patient’s individual perspectives of their illness, and thus to create the basis for 
an individualised programme of education and care, patients’ illness beliefs and expectations 
of self-efficacy should be routinely and systematically assessed. We recommend that 
information obtained from the illness beliefs and expectation assessment can be used to 
formulate a personalised patient education plan/protocol to help patient to understand their 
individual illness condition and to make sense of the recommended modifiable health 
behaviour changes.  
 
In line with previous research identifying effective personalised patient education to support 
self-management in chronic long term health conditions, this study also indicates that to 
effectively support self-management in ALD patients, appropriate patient education and 
guidance needs to: 
• help patients to assess the severity of their symptoms step by step, including to recognise 
whether the symptoms are related to their ALD condition;  
• interpret the severity and impact of the symptoms;  
• identify the appropriate response and action; and  
• establish how to monitor and evaluate progress. 
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Limitations  
Multiple regression analysis was used to identify the strength and pattern of association 
between the variables examined; however with the cross-sectional design it is not possible to 
establish the direction of the relationship. Data collection from ALD patients is known to be 
challenging and the project team did not have sufficient resources to carry out a longitudinal 
study. 
   
CONCLUSION 
The National Plan for Liver Service U.K. (BASL & BSG, 2009) calls for more research to 
better understand chronic liver disease patients’ experience to improve care. The current 
study provides valuable information about key components of ALD patients’ illness beliefs 
and their associations with confidence to self-manage their chronic condition (SEChronic) 
and their confidence to manage modifiable lifestyle changes (SELiver). Interventions 
designed to improve ALD patients’ understanding of their illness and the strategies to 
manage their symptoms are likely to improve their quality of life and reduce anxiety and 
depression and improve their confidence in self-management.  It is feasible to elicit patient 
illness beliefs using standardised questions and educate clinicians to utilise the information 
gained to provide effective personalised patient education to improve self-management. 
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Table 1: Demographic & illness characteristics (n=159) 
 
Demographic  
Age Mean 52.3 SD±10.9  Range 27-80 
  No. % 
Gender Female 48 30 
 Male 107 67 
 Unknown 4 3 
Marital status Single 30 19 
 Partner 18 11 
 Married 68 43 
 Divorced/separated/widowed 31 19 
 Unknown 12 8 
Do you live…. Alone 42 26 
 With somebody else  84 53 
 Other 15 9 
 Unknown 18 11 
Ethnicity White 128 81 
 BME/Mixed 25 16 
 Unknown 6 4 
Educational qualification None 29 18 
 GCSEs/ O levels 29 18 
 A Levels 15 9 
 University degree 39 25 
 Vocational /other qualification 16 10 
 Other 10 6 
 Unknown 21 13 
Employment status Employed 30 19 
 On sick leave 11 7 
 Home maker 11 7 
 Retired 30 19 
 Not employed 42 26 
 Other  19 12 
 Unknown 16 10 
 
Illness characteristics 
Comorbidities None  97 61 
 One or more 62 39 
Body Mass Index < 30 79 50 
 ≥30 26 16 
 Unknown 54 34 
Current smoker Yes 46 29 
 No 98 62 
 Unknown 15 9 
MELD score Mean 11.0 SD± 4.4 Range 6-28 
AUDIT C score Mean 3.46 SD±4.47 Range 0-12 
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Table 2:  
Illness belief, emotional state, self-management and quality of life – summary statistics 
 
Illness belief: 
 n Mean SD Range 
Consequences 159 5.77 3.03 0-10 
Timeline 152 7.74 2.80 0-10 
Personal control 158 3.99 2.90 0-10 
Treatment control 151 2.21 2.33 0-10 
Identity 158 5.32 3.04 0-10 
Concerns 157 7.42 2.92 0-10 
Understanding 157 2.15 2.41 0-10 
Emotions 157 5.50 3.32 0-10 
Symptoms (IPQ ‘identity’ scale) 157 2.19 0.61 1.07-3.73 
 
Emotional states: 
 
n Mean SD Range 
Anxiety 158 2.76 0.71 1.29-4.00 
Depression 158 3.14 0.61 1.57-4.00 
 
Self-management: 
    
 n Mean SD Range 
SE Chronic 154 5.79 2.53 0-10 
SE Liver 152 7.42 2.16 0.80-10.00 
 
Quality of life: 
    
 n Mean SD Range 
EQ5D 155 6.33 1.95 1-10 
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Table 3 ‘Symptoms’(IPQ identity dimension scale):  
Patients’ experience of each of the following symptoms in percentage (%), n=159. 
Symptoms:  
(How often you experience each of 
the following symptoms?) 
 
 
 
n 
Never / 
Occasionally 
 
% 
Frequently /  
All the time 
 
% 
Sleep difficulties 
152 
 
42.1 57.9 
Fatigue 150 44.7 55.4 
Sore joints 157 59.2 40.8 
Concern about illness complications 
155 
59.4 40.7 
Discomfort  
154 
62.3 37.7 
Decreased appetite 154 63.0 37.0 
Depression 
155 
63.2 36.8 
Irritability 
153 
65.4 34.6 
Worry about family situation 
155 
56.1 33.9 
Difficulty in concentrating 
156 
67.3 33.7 
Itch 155 71.0 29.0 
Swollen abdomen (ascites) 154 72.1 27.9 
Confusion or drowsiness 
(encephalopathy) 
153 
74.5 25.5 
Pain in the right upper abdomen 
155 
81.9 23.4 
Jaundice 
153 
91.5 8.5 
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Table 4: Regression analysis for illness and patient characteristics on emotional states 
a) Anxiety 
  β (95% CI) p-value 
Partial 
R
2
 
     Consequence 0.022 (-0.021 to 0.064) 0.31 0.011 
Timeline -0.021 (-0.059 to 0.017) 0.28 0.012 
Personal control -0.001 (-0.036 to 0.035) 0.97 0.000 
Treatment control 0.000 (-0.039 to 0.038) 0.99 0.000 
Identity  0.034 (-0.011 to 0.078) 0.14 0.023 
Concerns -0.009 (-0.047 to 0.029) 0.64 0.002 
Understanding -0.007 (-0.047 to 0.032) 0.71 0.001 
Emotions -0.070 (-0.113 to -0.027) 0.002 0.097 
Symptoms -0.768 (-0.997 to -0.538) <0.001 0.312 
MELD 0.006 (-0.016 to 0.027) 0.61 0.003 
Audit C -0.011 (-0.035 to 0.014) 0.38 0.008 
Age 0.003 (-0.005 to 0.012) 0.46 0.006 
Male 0.071 (-0.140 to 0.282) 0.51 0.005 
Married/partner 0.083 (-0.134 to 0.299) 0.45 0.006 
Living alone 0.106 (-0.143 to 0.355) 0.40 0.007 
Ethnicity- white -0.099 (-0.358 to 0.161) 0.45 0.006 
Education- degree 0.014 (-0.198 to 0.226) 0.90 0.000 
Comorbidities  0.006 (-0.169 to 0.181) 0.95 0.000 
BMI ≥ 30 -0.095 (-0.339 to 0.150) 0.45 0.006 
BMI unknown -0.181 (-0.402 to 0.040) 0.11 0.026 
Current smoker -0.127 (-0.337 to 0.084) 0.24 0.014 
Employment 0.002 (-0.257 to 0.261) 0.99 0.000 
          
Overall Model: F(22,97) = 10.34, p<0.001, Adjusted R2 = 0.63 
Continued 
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Table 4: Regression analysis for illness and patient characteristics on emotional 
states, continued 
b) Depression 
  β (95% CI) p-value 
Partial 
R
2
 
     Consequence -0.039 (-0.072 to -0.006) 0.022 0.053 
Timeline -0.002 (-0.032 to 0.028) 0.89 0.000 
Personal control -0.037 (-0.065 to -0.010) 0.009 0.068 
Treatment control 0.018 (-0.012 to 0.048) 0.24 0.014 
Identity  0.007 (-0.028 to 0.043) 0.67 0.002 
Concerns 0.018 (-0.012 to 0.048) 0.24 0.014 
Understanding -0.030 (-0.061 to 0.001) 0.061 0.036 
Emotions -0.037 (-0.071 to -0.004) 0.030 0.048 
Symptoms -0.375 (-0.555 to -0.194) <0.001 0.149 
MELD -0.008 (-0.025 to 0.009) 0.37 0.008 
Audit C -0.009 (-0.028 to 0.011) 0.37 0.008 
Age -0.001 (-0.008 to 0.005) 0.66 0.002 
Male 0.143 (-0.023 to 0.309) 0.090 0.029 
Married/partner -0.017 (-0.187 to 0.153) 0.85 0.000 
Living alone 0.133 (-0.062 to 0.329) 0.18 0.018 
Ethnicity- white -0.053 (-0.257 to 0.151) 0.61 0.003 
Education- degree 0.047 (-0.120 to 0.214) 0.58 0.003 
Comorbidities  -0.069 (-0.207 to 0.068) 0.32 0.010 
BMI ≥ 30 0.079 (-0.114 to 0.271) 0.42 0.007 
BMI unknown -0.038 (-0.211 to 0.136) 0.67 0.002 
Current smoker -0.231 (-0.396 to -0.065) 0.007 0.073 
Employment 0.068 (-0.135 to 0.272) 0.51 0.005 
          
Overall Model: F(22,97) = 12.91, p<0.001, Adjusted R2 = 0.69 
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Table 5: Regression analysis for illness perception and patient characteristics on 
Quality of Life EQ-5D 
  β (95% CI) p-value 
Partial 
R
2
 
     Consequence 0.122 (-0.040 to 0.285) 0.14 0.023 
Timeline 0.067 (-0.078 to 0.212) 0.36 0.009 
Personal control -0.086 (-0.221 to 0.049) 0.21 0.017 
Treatment control 0.015 (-0.134 to 0.164) 0.84 0.000 
Identity  -0.088 (-0.258 to 0.083) 0.31 0.011 
Concerns -0.057 (-0.202 to 0.088) 0.44 0.006 
Understanding -0.135 (-0.286 to 0.015) 0.078 0.032 
Emotions -0.070 (-0.234 to 0.094) 0.40 0.007 
Symptoms -0.915 (-1.799 to -0.031) 0.043 0.043 
MELD 0.040 (-0.043 to 0.124) 0.34 0.010 
Audit C -0.042 (-0.135 to 0.051) 0.37 0.008 
Age -0.019 (-0.052 to 0.014) 0.25 0.014 
Male 0.001 (-0.818 to 0.820) 1.00 0.000 
Married/partner -0.152 (-0.979 to 0.676) 0.72 0.001 
Living alone 0.038 (-0.912 to 0.988) 0.94 0.000 
Ethnicity- white -0.336 (-1.332 to 0.660) 0.51 0.005 
Education- degree -0.010 (-0.828 to 0.809) 0.98 0.000 
Comorbidities  -0.647 (-1.320 to 0.026) 0.059 0.037 
BMI ≥ 30 0.317 (-0.628 to 1.262) 0.51 0.005 
BMI unknown -0.337 (-1.190 to 0.515) 0.43 0.006 
Current smoker -0.765 (-1.590 to 0.060) 0.069 0.034 
Employment 0.765 (-0.223 to 1.752) 0.13 0.024 
          
Overall Model: F(22,97) = 3.79, p<0.001, Adjusted R2 = 0.34 
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Table 6: Regression analysis for illness perception and patient characteristics on 
Self-management 
a) SE Chronic 
  β (95% CI) p-value 
Partial 
R
2
 
     Consequence -0.067 (-0.229 to 0.096) 0.42 0.007 
Timeline -0.083 (-0.230 to 0.064) 0.27 0.013 
Personal control -0.222 (-0.360 to -0.085) 0.002 0.097 
Treatment control -0.160 (-0.310 to -0.011) 0.035 0.045 
Identity  -0.040 (-0.211 to 0.131) 0.64 0.002 
Concerns -0.111 (-0.257 to 0.035) 0.13 0.023 
Understanding -0.137 (-0.290 to 0.017) 0.080 0.032 
Emotions -0.047 (-0.212 to 0.118) 0.57 0.003 
Symptoms -1.841 (-2.721 to -0.960) <0.001 0.152 
MELD 0.067 (-0.017 to 0.150) 0.12 0.025 
Audit C -0.019 (-0.112 to 0.075) 0.70 0.002 
Age -0.007 (-0.039 to 0.026) 0.69 0.002 
Male -0.070 (-0.880 to 0.740) 0.86 0.000 
Married/partner -0.380 (-1.210 to 0.450) 0.37 0.009 
Living alone -0.197 (-1.151 to 0.757) 0.68 0.002 
Ethnicity- white -0.388 (-1.387 to 0.610) 0.44 0.006 
Education- degree -0.139 (-0.952 to 0.675) 0.74 0.001 
Comorbidities  0.002 (-0.677 to 0.681) 1.00 0.000 
BMI ≥ 30 0.398 (-0.563 to 1.360) 0.41 0.007 
BMI unknown 0.187 (-0.660 to 1.033) 0.66 0.002 
Current smoker 0.248 (-0.559 to 1.055) 0.54 0.004 
Employment 0.154 (-0.847 to 1.156) 0.76 0.001 
          
Overall Model: F(22,96) = 8.92, p<0.001, Adjusted R2 = 0.60 
Continued 
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Table 6: Regression analysis for illness perception and patient characteristics on 
Self-management, continued 
b) SE Liver 
 
  β (95% CI) p-value 
Partial 
R
2
 
     Consequence -0.083 (-0.228 to 0.062) 0.26 0.013 
Timeline -0.002 (-0.133 to 0.130) 0.98 0.000 
Personal control -0.054 (-0.177 to 0.068) 0.38 0.008 
Treatment control -0.075 (-0.208 to 0.058) 0.27 0.013 
Identity  0.030 (-0.123 to 0.182) 0.70 0.002 
Concerns 0.186 (0.056 to 0.317) 0.006 0.077 
Understanding -0.201 (-0.338 to -0.065) 0.004 0.082 
Emotions -0.049 (-0.196 to 0.098) 0.51 0.005 
Symptoms -1.386 (-2.172 to -0.601) 0.001 0.113 
MELD 0.000 (-0.075 to 0.074) 1.00 0.000 
Audit C -0.154 (-0.238 to -0.071) <0.001 0.122 
Age -0.006 (-0.035 to 0.024) 0.70 0.002 
Male -0.976 (-1.699 to -0.253) 0.009 0.070 
Married/partner -0.585 (-1.325 to 0.155) 0.12 0.025 
Living alone -0.584 (-1.436 to 0.267) 0.18 0.019 
Ethnicity- white 0.231 (-0.659 to 1.122) 0.61 0.003 
Education- degree 0.507 (-0.219 to 1.234) 0.17 0.020 
Comorbidities  -0.229 (-0.835 to 0.377) 0.46 0.006 
BMI ≥ 30 -0.098 (-0.956 to 0.760) 0.82 0.001 
BMI unknown -0.664 (-1.420 to 0.091) 0.084 0.031 
Current smoker -0.839 (-1.559 to -0.119) 0.023 0.053 
Employment -0.008 (-0.902 to 0.885) 0.99 0.000 
          
Overall Model: F(22,96) = 6.21, p<0.001, Adjusted R2 = 0.49 
 
 
